Lung Cancer is the second most common form of cancer worldwide. Small-cell lung cancer (SCLC) represents about 10% to 15% of all lung cancers. It is a form of neuroendocrine tumor, classified into limited and extensive-stage disease. Chemotherapy remains the standard line of treatment for SCLC. SCLC remains challenging for treatment as it has aggressive